Back

The semaglutide paradox in non-overweight diabetes: a benefit without explanation

European Heart Journal - Quality of Care and Clinical Outcomes

11 August 2025
Organised by: Logo
Read full article
ESC Journals

Contributors

Ahmed B Shamsulddin
Ahmed B Shamsulddin

Author

Al-Yarmouk Teaching Hospital Baghdad , Iraq

ESC 365 is supported by

novartis Explore sponsored resources